Dynamic in vivo mutations within the ica operon during persistence of Staphylococcus aureus in the airways of cystic fibrosis patients

Cystic fibrosis (CF) is associated with chronic bacterial airway infections leading to lung insufficiency and decreased life expectancy. Staphylococcus aureus is one of the most prevalent pathogens isolated from the airways of CF patients. Mucoid colony morphology has been described for Pseudomonas aeruginosa, the most common pathogen in CF, but not for S. aureus. From the airways of 8 of 313 CF patients (2.5%) mucoid S. aureus isolates (n = 115) were cultured with a mean persistence of 29 months (range 1 month, 126 months). In contrast to non-mucoid S. aureus, mucoid isolates were strong biofilm formers. The upstream region of the ica operon, which encodes the proteins responsible for the synthesis of the polysaccharide intercellular adhesin (PIA), of mucoid isolates was sequenced. Spa-types of mucoid and non-mucoid strains were identical, but differed between patients. Mucoid isolates carried a 5 bp deletion in the intergenic region between icaR and icaA. During long-term persistence, from two patients subsequent non-mucoid isolates (n = 12) with 5 bp deletions were cultured, which did not produce biofilm. Sequencing of the entire ica operon identified compensatory mutations in various ica-genes including icaA (n = 7), icaD (n = 3) and icaC (n = 2). Six sequential isolates of each of these two patients with non-mucoid and mucoid phenotypes were subjected to whole genome sequencing revealing a very close relationship of the individual patient’s isolates. Transformation of strains with vectors expressing the respective wild-type genes restored mucoidy. In contrast to the non-mucoid phenotype, mucoid strains were protected against neutrophilic killing and survived better under starvation conditions. In conclusion, the special conditions present in CF airways seem to facilitate ongoing mutations in the ica operon during S. aureus persistence.

[1]  A. Mellmann,et al.  Real-Time Genome Sequencing of Resistant Bacteria Provides Precision Infection Control in an Institutional Setting , 2016, Journal of Clinical Microbiology.

[2]  J. O’Gara,et al.  Untangling the Diverse and Redundant Mechanisms of Staphylococcus aureus Biofilm Formation , 2016, PLoS pathogens.

[3]  E. Liebau,et al.  Inactivation of thyA in Staphylococcus aureus Attenuates Virulence and Has a Strong Impact on Metabolism and Virulence Gene Expression , 2014, mBio.

[4]  K. Jefferson,et al.  Phase Variation of Poly-N-Acetylglucosamine Expression in Staphylococcus aureus , 2014, PLoS pathogens.

[5]  Dag Harmsen,et al.  Bacterial Whole-Genome Sequencing Revisited: Portable, Scalable, and Standardized Analysis for Typing and Detection of Virulence and Antibiotic Resistance Genes , 2014, Journal of Clinical Microbiology.

[6]  Richard G. Everitt,et al.  Within-Host Evolution of Staphylococcus aureus during Asymptomatic Carriage , 2013, PloS one.

[7]  Julian Parkhill,et al.  Whole-genome sequencing for analysis of an outbreak of meticillin-resistant Staphylococcus aureus: a descriptive study , 2013, The Lancet. Infectious Diseases.

[8]  M. Otto Staphylococcal infections: mechanisms of biofilm maturation and detachment as critical determinants of pathogenicity. , 2013, Annual review of medicine.

[9]  D. Qu,et al.  The Two-Component Signal Transduction System ArlRS Regulates Staphylococcus epidermidis Biofilm Formation in an ica-Dependent Manner , 2012, PloS one.

[10]  A. Prince,et al.  Cystic fibrosis: a mucosal immunodeficiency syndrome , 2012, Nature Medicine.

[11]  C. Weidenmaier,et al.  Characterization of the Structure and Biological Functions of a Capsular Polysaccharide Produced by Staphylococcus saprophyticus , 2010, Journal of bacteriology.

[12]  Samuel I. Miller,et al.  Nutrient Availability as a Mechanism for Selection of Antibiotic Tolerant Pseudomonas aeruginosa within the CF Airway , 2010, PLoS pathogens.

[13]  H. Rohde,et al.  Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. , 2010, European journal of cell biology.

[14]  S. Foster,et al.  Molecular Characterization of a Novel Staphylococcus Aureus Surface Protein (SasC) Involved in Cell Aggregation and Biofilm Accumulation , 2009, PloS one.

[15]  C. Wolz,et al.  The staphylococcal respiratory response regulator SrrAB induces ica gene transcription and polysaccharide intercellular adhesin expression, protecting Staphylococcus aureus from neutrophil killing under anaerobic growth conditions , 2007, Molecular microbiology.

[16]  P. Vandamme,et al.  DNA-DNA hybridization values and their relationship to whole-genome sequence similarities. , 2007, International journal of systematic and evolutionary microbiology.

[17]  C. Wolz,et al.  Staphylococcus aureus strain designation by agr and cap polymorphism typing and delineation of agr diversification by sequence analysis. , 2005, International journal of medical microbiology : IJMM.

[18]  A. Watts,et al.  Staphylococcus aureus Strains That Express Serotype 5 or Serotype 8 Capsular Polysaccharides Differ in Virulence , 2005, Infection and Immunity.

[19]  I. Sadovskaya,et al.  Extracellular Carbohydrate-Containing Polymers of a Model Biofilm-Producing Strain, Staphylococcus epidermidis RP62A , 2005, Infection and Immunity.

[20]  M. Kosorok,et al.  Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis. , 2005, JAMA.

[21]  Georg Peters,et al.  Variation of the Polymorphic Region X of the Protein A Gene during Persistent Airway Infection of Cystic Fibrosis Patients Reflects Two Independent Mechanisms of Genetic Change in Staphylococcus aureus , 2005, Journal of Clinical Microbiology.

[22]  Yufeng Yao,et al.  A Crucial Role for Exopolysaccharide Modification in Bacterial Biofilm Formation, Immune Evasion, and Virulence* , 2004, Journal of Biological Chemistry.

[23]  Michael Otto,et al.  Polysaccharide intercellular adhesin (PIA) protects Staphylococcus epidermidis against major components of the human innate immune system , 2004, Cellular microbiology.

[24]  Katherine O'Riordan,et al.  Staphylococcus aureus Capsular Polysaccharides , 2004, Clinical Microbiology Reviews.

[25]  J. Rothgänger,et al.  Typing of Methicillin-Resistant Staphylococcus aureus in a University Hospital Setting by Using Novel Software for spa Repeat Determination and Database Management , 2003, Journal of Clinical Microbiology.

[26]  Friedrich Götz,et al.  Identification of a 5‐nucleotide sequence that controls expression of the ica locus in Staphylococcus aureus and characterization of the DNA‐binding properties of IcaR , 2003, Molecular microbiology.

[27]  F. Ratjen,et al.  Cystic fibrosis , 2003, The Lancet.

[28]  E. Böttger,et al.  Fitness Cost of Chromosomal Drug Resistance-Conferring Mutations , 2002, Antimicrobial Agents and Chemotherapy.

[29]  J. Costerton,et al.  Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms , 2002, Clinical Microbiology Reviews.

[30]  Richard C Boucher,et al.  Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. , 2002, The Journal of clinical investigation.

[31]  S. Cramton,et al.  Anaerobic Conditions Induce Expression of Polysaccharide Intercellular Adhesin in Staphylococcus aureus and Staphylococcus epidermidis , 2001, Infection and Immunity.

[32]  M. Otto,et al.  Impact of the agr quorum-sensing system on adherence to polystyrene in Staphylococcus aureus. , 2000, The Journal of infectious diseases.

[33]  L. Steele-Moore,et al.  Capsule Expression by Bovine Isolates ofStaphylococcus aureus from Argentina: Genetic and Epidemiologic Analyses , 2000, Journal of Clinical Microbiology.

[34]  S. Cramton,et al.  The Intercellular Adhesion (ica) Locus Is Present in Staphylococcus aureus and Is Required for Biofilm Formation , 1999, Infection and Immunity.

[35]  D. Goldmann,et al.  Broadly protective vaccine for Staphylococcus aureus based on an in vivo-expressed antigen. , 1999, Science.

[36]  R. Süssmuth,et al.  Characterization of theN-Acetylglucosaminyltransferase Activity Involved in the Biosynthesis of the Staphylococcus epidermidisPolysaccharide Intercellular Adhesin* , 1998, The Journal of Biological Chemistry.

[37]  Roberto Kolter,et al.  Initiation of biofilm formation in Pseudomonas fluorescens WCS365 proceeds via multiple, convergent signalling pathways: a genetic analysis , 1998, Molecular microbiology.

[38]  R. Süssmuth,et al.  Characterization of the N-acetylglucosaminyltransferase activity involved in the biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular adhesin. , 1998, The Journal of biological chemistry.

[39]  V. Deretic,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: characterization of muc mutations in clinical isolates and analysis of clearance in a mouse model of respiratory infection , 1997, Infection and immunity.

[40]  Channing,et al.  Effects of in vitro and in vivo growth conditions on expression of type 8 capsular polysaccharide by Staphylococcus aureus , 1993, Infection and immunity.

[41]  M. Liu,et al.  Expression of type 8 capsular polysaccharide and production of toxic shock syndrome toxin 1 are associated among vaginal isolates of Staphylococcus aureus , 1990, Journal of clinical microbiology.

[42]  D. Martin,et al.  Mucoid Pseudomonas aeruginosa in cystic fibrosis: mutations in the muc loci affect transcription of the algR and algD genes in response to environmental stimuli , 1990, Molecular microbiology.

[43]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.